Allogeneic blood transfusion and the prognosis of gastric cancer patients: Systematic review and meta-analysis

International Journal of Surgery

Volumn 13, Issue , 2015, Pages 102-110

  Sun, Chang ^a   Wang, Yi ^a   Yao, Hou Shan ^a   Hu, Zhi Qian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Allogeneic blood transfusion; Curative surgery; Gastric cancer; Prognosis

Indexed keywords

HEMOGLOBIN;

ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; FOLLOW UP; GASTRECTOMY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LYMPH NODE DISSECTION; META ANALYSIS; OPERATION DURATION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SPLENECTOMY; STOMACH CANCER; SYSTEMATIC REVIEW; TOTAL STOMACH RESECTION; TUMOR VOLUME; ADVERSE EFFECTS; CAUSE OF DEATH; MORTALITY; PROGNOSIS; RISK; RISK FACTOR; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR RECURRENCE;

BLOOD TRANSFUSION; CAUSE OF DEATH; HUMANS; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84942814264     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2014.11.044     Document Type: Article

References (54)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: A Cancer J. Clin. 2011, 61:69-90.
2. Japanese classification of gastric carcinoma: 3rd english edition. Gastric Cancer 2011, 14:101-112.
3. Sugezawa A., Kaibara N., Sumi K., Ohta M., Kimura O., Nishidoi H., Koga S. Blood transfusion and the prognosis of patients with gastric cancer. J.Surg. Oncol. 1989, 42:113-116.
4. Fong Y., Karpeh M., Mayer K., Brennan M.F. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am. J. Surg. 1994, 167:256-260.
5. Maeta M., Shimizu N., Oka A., Kondo A., Yamashiro H., Tsujitani S., Ikegchi M., Kaibara N. Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J.Surg. Oncol. 1994, 55:149-153.
6. Kinugasa S., Abe S., Tachibana M., Yoshimura H., Monden N., Dhar D.K., Nagasue N., Harada Y., Nagaoka S. Surgically curable and incurable scirrhous carcinomas of the stomach. J.Surg. Oncol. 1997, 65:194-200.
7. Haga Y., Yagi Y., Ogawa M. Less-invasive surgery for gastric cancer prolongs survival in patients over 80 years of age. Surg. Today 1999, 29:842-848.
8. Dhar D.K., Kubota H., Tachibana M., Kotoh T., Kinugasa S., Shibakita M., Kohno H., Nagasue N. Atailored perioperative blood transfusion might avoid undue recurrences in gastric carcinoma patients. Dig. Dis. Sci. 2000, 45:1737-1742.
9. Murata N., Idezuki Y., Konishi T., Watanabe H., Ushirokoji Y., Shinohara K., Shibusawa M., Haga S., Hiraishi M., Bandai Y., Yamamura T., Yumoto S., Gunji A., Nishigaki K. Influence of perioperative blood transfusion on the prognosis of patients with gastric cancer receiving anticancer chemotherapy. Gastric Cancer 2000, 3:24-27.
10. Hyung W.J., Noh S.H., Shin D.W., Huh J., Huh B.J., Choi S.H., Min J.S. Adverse effects of perioperative transfusion on patients with stage iii and iv gastric cancer. Ann. Surg. Oncol. 2002, 9:5-12.
11. Weitz J., D'Angelica M., Gonen M., Klimstra D., Coit D.G., Brennan M.F., Karpeh M.S. Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer. J.Clin. Oncol.:Official J. Am. Soc. Clin. Oncol. 2003, 21:4597-4603.
12. Shen J.G., Cheong J.H., Hyung W.J., Kim J., Choi S.H., Noh S.H. Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am. J. Surg. 2006, 192:301-305.
13. Yamashita K., Sakuramoto S., Kikuchi S., Katada N., Kobayashi N., Watanabe M. Transfusion alert for patients with curable cancer. World J. Surg. 2007, 31:2315-2322.
14. Wang X., Wan F., Pan J., Yu G.Z., Chen Y., Wang J.J. Tumor size: a non-neglectable independent prognostic factor for gastric cancer. J.Surg. Oncol. 2008, 97:236-240.
15. Ojima T., Iwahashi M., Nakamori M., Nakamura M., Naka T., Katsuda M., Iida T., Hayata K., Yamaue H. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J.Gastrointest. Surg.:Official J. Soc. Surg. Alimentary Tract 2009, 13:1821-1830.
16. Tsujimoto H., Ichikura T., Ono S., Sugasawa H., Hiraki S., Sakamoto N., Yaguchi Y., Yoshida K., Matsumoto Y., Hase K. Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Ann. Surg. Oncol. 2009, 16:311-318.
17. Kim S.H., Lee S.I., Noh S.M. Prognostic significance of preoperative blood transfusion in stomach cancer. J.Gastric Cancer 2010, 10:196-205.
18. Moriguchi S., Maehara Y., Akazawa K., Sugimachi K., Nose Y. Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer. Cancer 1990, 66:2331-2335.
19. Choi J.H., Chung H.C., Yoo N.C., Lee H.R., Lee K.H., Kim J.H., Roh J.K., Min J.S., Lee K.S., Kim B.S., et al. Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer. Oncology 1995, 52:170-175.
20. Sanchez-Bueno F., Garcia-Marcilla J.A., Perez-Abad J.M., Vicente R., Aranda F., Lujan J.A., Parrilla P. Does perioperative blood transfusion influence long-term prognosis of gastric cancer?. Dig. Dis. Sci. 1997, 42:2072-2076.
21. Shen J.G., Cheong J.H., Hyung W.J., Kim J., Choi S.H., Noh S.H. Pretreatment anemia is associated with poorer survival in patients with stage i and ii gastric cancer. J.Surg. Oncol. 2005, 91:126-130.
22. Nazli O., Derici H., Tansug T., Yaman I., Bozdag A.D., Isguder A.S., Bolukbasi H. Survival analysis after surgical treatment of gastric cancer: review of 121 cases. Hepato-gastroenterology 2007, 54:625-629.
23. Pacelli F., Rosa F., Marrelli D., Pedrazzani C., Bossola M., Zoccali M., Marchet A., Di Cosmo M., Roata C., Graziosi L., Cavazzoni E., Covino M., D'Ugo D., Roviello F., Nitti D., Doglietto G.B. Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann. Surg. Oncol. 2011, 18:1615-1623.
24. Li Q.G., Li P., Tang D., Chen J., Wang D.R. Impact of postoperative complications on long-term survival after radical resection for gastric cancer. World J. Gastroenterology:WJG 2013, 19:4060-4065.
25. Rausei S., Ruspi L., Galli F., Tirotta F., Inversini D., Frattini F., Chiappa C., Rovera F., Boni L., Dionigi G., Dionigi R. Peri-operative blood transfusion in gastric cancer surgery: prognostic or confounding factor?. Int. J. Surg. 2013, 11(Suppl.1):S100-S103.
26. Heiss M.M., Allgayer H., Gruetzner K.U., Tarabichi A., Babic R., Mempel W., Jauch K.W., Schildberg F.W. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Res. 1997, 17:2657-2661.
27. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA:J. Am. Med. Assoc. 2000, 283:2008-2012.
28. Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010, 25:603-605.
29. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Statistics Med. 2002, 21:1539-1558.
30. Whitehead A., Whitehead J. Ageneral parametric approach to the meta-analysis of randomized clinical trials. Statistics Med. 1991, 10:1665-1677.
31. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
32. Ajani J.A., Kelsen D.P., Haller D., Hargraves K., Healey D. Amulti-institutional phase ii study of bms-182248-01 (br96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma. Cancer J. 2000, 6:78-81.
33. Acheson A.G., Brookes M.J., Spahn D.R. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann. Surg. 2012, 256:235-244.
34. Little A.G., Wu H.S., Ferguson M.K., Ho C.H., Bowers V.D., Segalin A., Staszek V.M. Perioperative blood transfusion adversely affects prognosis of patients with stage i non-small-cell lung cancer. Am. J. Surg. 1990, 160:630-632. discussion 633.
35. Tartter P.I., Burrows L., Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of stage i (subset n0) non-oat cell lung cancer. J.Thorac. Cardiovasc Surg. 1984, 88:659-662.
36. Moores D.W., Piantadosi S., McKneally M.F. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann. Thorac. Surg. 1989, 47:346-351.
37. Crowe J.P., Gordon N.H., Fry D.E., Shuck J.M., Hubay C.A. Breast cancer survival and perioperative blood transfusion. Surgery 1989, 106:836-841.
38. Sun C.F., Hsieh Y.Y., Ngan K.W., Wang W.T. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of th1/th2 cells in peripheral blood. Ann. Clin. Lab. Sci. 2001, 31:171-178.
39. Chen G., Zhang F.J., Gong M., Yan M. Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. J.Zhejiang Univ. Sci. B 2007, 8:560-565.
40. Baumgartner J.M., Silliman C.C., Moore E.E., Banerjee A., McCarter M.D. Stored red blood cell transfusion induces regulatory t cells. J.Am. Coll. Surg. 2009, 208:110-119.
41. Zhang H., Chua K.S., Guimond M., Kapoor V., Brown M.V., Fleisher T.A., Long L.M., Bernstein D., Hill B.J., Douek D.C., Berzofsky J.A., Carter C.S., Read E.J., Helman L.J., Mackall C.L. Lymphopenia and interleukin-2 therapy alter homeostasis of cd4+cd25+ regulatory t cells. Nat. Med. 2005, 11:1238-1243.
42. Heiss M.M., Simon E.H., Beyer B.C., Gruetzner K.U., Tarabichi A., Babic R., Schildberg F.W., Allgayer H. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. J.Clin. Oncol.: Official J. Am. Soc. Clin. Oncol. 2002, 20:2005-2016.
43. Marsh J., Donnan P.T., Hamer-Hodges D.W. Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br. J. Surg. 1990, 77:623-626.
44. Blumberg N., Heal J.M., Murphy P., Agarwal M.M., Chuang C. Association between transfusion of whole blood and recurrence of cancer. Br. Med. J. (Clin. Res. Ed.) 1986, 293:530-533.
45. Bordin J.O., Heddle N.M., Blajchman M.A. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994, 84:1703-1721.
46. Lagaaij E.L., Hennemann I.P., Ruigrok M., de Haan M.W., Persijn G.G., Termijtelen A., Hendricks G.F., Weimar W., Claas F.H., van Rood J.J. Effect of one-hla-dr-antigen-matched and completely hla-dr-mismatched blood transfusions on survival of heart and kidney allografts. N.Engl. J. Med. 1989, 321:701-705.
47. Pierce L.E., Beall C.L. Current transfusion practices. Am. Fam. Physician 1975, 11:129-136.
48. Houbiers J.G., Brand A., van de Watering L.M., Hermans J., Verwey P.J., Bijnen A.B., Pahlplatz P., Eeftinck Schattenkerk M., Wobbes T., de Vries J.E., et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994, 344:573-578.
49. Jensen L.S., Puho E., Pedersen L., Mortensen F.V., Sorensen H.T. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 2005, 365:681-682.
50. Busch O.R., Hop W.C., Hoynck van Papendrecht M.A., Marquet R.L., Jeekel J. Blood transfusions and prognosis in colorectal cancer. N.Engl. J. Med. 1993, 328:1372-1376.
51. Harlaar J.J., Gosselink M.P., Hop W.C., Lange J.F., Busch O.R., Jeekel H. Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial. Ann. Surg. 2012, 256:681-686. discussion 686-687.
52. Shander A., Van Aken H., Colomina M.J., Gombotz H., Hofmann A., Krauspe R., Lasocki S., Richards T., Slappendel R., Spahn D.R. Patient blood management in Europe. Br. J. Anaesth. 2012, 109:55-68.
53. Lee K.Y., Noh S.H., Hyung W.J., Lee J.H., Lah K.H., Choi S.H., Min J.S. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer. Ann. Surg. Oncol. 2001, 8:402-406.
54. Gombotz H. Patient blood management: a patient-orientated approach to blood replacement with the goal of reducing anemia, blood loss and the need for blood transfusion in elective surgery. Transfus. Med. hemotherapy: Offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2012, 39:67-72.